These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16809935)

  • 1. Oxidative stress in vero cells infected with vesicular stomatitis virus.
    Riva DA; de Molina MC; Rocchetta I; Gerhardt E; Coulombié FC; Mersich SE
    Intervirology; 2006; 49(5):294-8. PubMed ID: 16809935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis as pathogenic mechanism of infection with vesicular stomatitis virus. Evidence in primary bovine fibroblast cultures.
    López-Herrera A; Ruiz-Sáenz J; Góez YP; Zapata W; Velilla PA; Arango AE; Urcuqui-Inchima S
    Biocell; 2009 Aug; 33(2):121-32. PubMed ID: 19886040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular stomatitis virus induces apoptosis at early stages in the viral cycle and does not depend on virus replication.
    Gadaleta P; Vacotto M; Coulombié F
    Virus Res; 2002 Jun; 86(1-2):87-92. PubMed ID: 12076832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
    Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
    Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early activation of the mitochondrial apoptotic pathway in Vesicular Stomatitis virus-infected cells.
    Gadaleta P; Perfetti X; Mersich S; Coulombié F
    Virus Res; 2005 Apr; 109(1):65-9. PubMed ID: 15826914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID.
    Yuan H; Yoza BK; Lyles DS
    Virology; 1998 Nov; 251(2):383-92. PubMed ID: 9837802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
    Kim GN; Kang CY
    Virology; 2007 Jan; 357(1):41-53. PubMed ID: 16962155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular stomatitis virus infection triggers apoptosis associated with decreased DeltaNp63alpha and increased Bax levels in the immortalized HaCaT keratinocyte cell line.
    Megyeri K; Orosz L; Kemény L
    Biomed Pharmacother; 2007 Jun; 61(5):254-60. PubMed ID: 17459650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
    Ahmed M; Cramer SD; Lyles DS
    Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB activation Is delayed in mouse L929 cells infected with interferon suppressing, but not inducing, vesicular stomatitis virus strains.
    Boulares AH; Ferran MC; Lucas-Lenard J
    Virology; 1996 Apr; 218(1):71-80. PubMed ID: 8615043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vesicular stomatitis virus infection by nitric oxide.
    Bi Z; Reiss CS
    J Virol; 1995 Apr; 69(4):2208-13. PubMed ID: 7533852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on high-density cultivation of Vero cells with biosilon solid microcarrier.
    Wang D; Xiao C; Chen Z; Huang Z
    Chin J Biotechnol; 1996; 12(2):119-29. PubMed ID: 8988358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
    Schmidt MR; Gravel KA; Woodland RT
    J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral effect of a synthetic brassinosteroid on the replication of vesicular stomatitis virus in Vero cells.
    Romanutti C; Castilla V; Coto CE; Wachsman MB
    Int J Antimicrob Agents; 2007 Mar; 29(3):311-6. PubMed ID: 17275263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus.
    Koyama AH
    Virus Res; 1995 Aug; 37(3):285-90. PubMed ID: 8533463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.
    Ahmed M; Lyles DS
    Virology; 1997 Oct; 237(2):378-88. PubMed ID: 9356348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.
    Kalinke U; Krebber A; Krebber C; Bucher E; Plückthun A; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1996 Dec; 26(12):2801-6. PubMed ID: 8977271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoprotective and antioxidant role of diallyl tetrasulfide on cadmium induced renal injury: an in vivo and in vitro study.
    Pari L; Murugavel P; Sitasawad SL; Kumar KS
    Life Sci; 2007 Jan; 80(7):650-8. PubMed ID: 17125799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.